<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02299232</url>
  </required_header>
  <id_info>
    <org_study_id>295/25.02.2014</org_study_id>
    <nct_id>NCT02299232</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation</brief_title>
  <acronym>DEX</acronym>
  <official_title>Comparison of Two Different Intranasal Doses of Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sisli Hamidiye Etfal Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sisli Hamidiye Etfal Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sixty patients aged between 1-10 years, American Society of Anesthesia (ASA) physical status&#xD;
      I-II scheduled for MRI were allocated in this randomized double-blinded study. Group 1&#xD;
      received 3 mcg/kg, Group 2 received 4 mcg/kg intranasal dexmedetomidine before imaging. From&#xD;
      the beginning on every 10 minutes heart rate (HR), saturation (SpO2) and Ramsey Sedation&#xD;
      Score (RSS) were recorded. Induction time was time interval to receive RSS 5. MRI began and&#xD;
      separation-score was noted. If intranasal sedation failed, an intravenous canula was placed&#xD;
      and propofol was applied. Imaging quality was evaluated. Recovery time was time interval to&#xD;
      receive Aldrete-score 9. Parents' satisfaction was questioned before patient was discharged.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES OF STUDY Anesthetic agents used for MRI in paediatrics should have few adverse&#xD;
      effects, allow fast induction and recovery. The administration route is also important and&#xD;
      should be minimally invasive. In this study the investigators aimed to compare two different&#xD;
      doses of intranasal dexmedetomidine applied to children for MRI sedation.&#xD;
&#xD;
      MATERIALS AND METHODS Sixty patients aged between 1-10 years, ASA I-II scheduled for MRI were&#xD;
      allocated in this randomized double-blinded study. Group 1 received 3 mcg/kg, Group 2&#xD;
      received 4 mcg/kg intranasal dexmedetomidine before imaging. From the beginning on every 10&#xD;
      minutes HR, SpO2 and RSS were recorded. Induction time was time interval to receive RSS 5.&#xD;
      MRI began and separation-score was noted. If intranasal sedation failed, an intravenous&#xD;
      canula was placed and propofol was applied. Imaging quality was evaluated. Recovery time was&#xD;
      time interval to receive Aldrete-score 9. Parents' satisfaction was questioned before patient&#xD;
      was discharged.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ramsey Sedation Score</measure>
    <time_frame>every 10 minutes for a two hours period</time_frame>
    <description>a score to determine sedation deepness</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine 3mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexmedetomidine 3 mcg/kg intranasal 50 minutes before MRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine 4mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexmedetomidine 4 mcg/kg intranasal 50 minutes before MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Drug: dexmedetomidine 100 mcg/mL was applied in 3 mcg/kg and 4 mcg/kg doses in 1 mL preperates, 0.5 mL for each nostril</description>
    <arm_group_label>dexmedetomidine 3mcg/kg</arm_group_label>
    <arm_group_label>dexmedetomidine 4mcg/kg</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  MRI&#xD;
&#xD;
          -  ASA I-II&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hepatic and renal failure&#xD;
&#xD;
          -  difficult airway&#xD;
&#xD;
          -  nasal deformity&#xD;
&#xD;
          -  anaphylaxis to dexmedetomidine&#xD;
&#xD;
          -  neurologic disease&#xD;
&#xD;
          -  metabolic disorders&#xD;
&#xD;
          -  electrolyte imbalance&#xD;
&#xD;
          -  dehydration&#xD;
&#xD;
          -  malnutrition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hacer Sebnem Turk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sisli Hamidiye Etfal Training and Research Hospital</affiliation>
  </overall_official>
  <reference>
    <citation>Ambi US, Joshi C, Ganeshnavar A, Adarsh E. Intranasal dexmedetomidine for paediatric sedation for diagnostic magnetic resonance imaging studies. Indian J Anaesth. 2012 Nov;56(6):587-8. doi: 10.4103/0019-5049.104588.</citation>
    <PMID>23325950</PMID>
  </reference>
  <reference>
    <citation>Gyanesh P, Haldar R, Srivastava D, Agrawal PM, Tiwari AK, Singh PK. Comparison between intranasal dexmedetomidine and intranasal ketamine as premedication for procedural sedation in children undergoing MRI: a double-blind, randomized, placebo-controlled trial. J Anesth. 2014 Feb;28(1):12-8. doi: 10.1007/s00540-013-1657-x. Epub 2013 Jun 26.</citation>
    <PMID>23800984</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>November 5, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sisli Hamidiye Etfal Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Canan Tulay ISIL</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>sedation</keyword>
  <keyword>MRI</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

